Where clinical trials are planned for the Janssen, Sinovac and ... - dofaq.co
Where clinical trials are planned for the Janssen, Sinovac and ...
Philstar.com - 23 Jan 2021
Belgium-based firm Janssen Pharmaceutica and Chinese drugmakers Sinovac Biotech and Clover Biopharmaceuticals have secured approval from the ...
Bivalent RSV Vaccine Candidate For Young Adults Demonstrates Neutralizing Antibody Responses
Precision Vaccinations - 08 Apr 2024
Bivalent RSV Vaccine Candidate For Young Adults Demonstrates Neutralizing Antibody Responses ...
Clover introduces Covid-19 subunit vaccine in China
Pharmaceutical Technology - 15 Feb 2023
Clover introduces Covid-19 subunit vaccine in China ...
Gavi signs agreement with Clover Biopharmaceuticals for supply to COVAX
Gavi, the Vaccine Alliance - 30 Jun 2021
Gavi signs agreement with Clover Biopharmaceuticals for supply to COVAX ...
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young ...
Investing.com India - 08 Apr 2024
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young ... ...
Clover Biopharma's new trimeric subunit vaccine candidate prevents COVID-19 in monkeys
News-Medical.Net - 28 Sep 2020
Clover Biopharma's new trimeric subunit vaccine candidate prevents COVID-19 in monkeys ...
Clover Expands Sales and Distribution Network for Upcoming Quadrivalent Seasonal Influenza Vaccine Launch in China
GlobeNewswire - 23 May 2023
Clover Expands Sales and Distribution Network for Upcoming Quadrivalent Seasonal Influenza Vaccine Launch in China ...
Covid-19 vaccines in PH: What to know
pna.gov.ph - 08 Jan 2021
Covid-19 vaccines in PH: What to know ...
FDA approves clinical trial for Clover COVID-19 vaccine
GMA News Online - 08 Jan 2021
FDA approves clinical trial for Clover COVID-19 vaccine ...
Chinese COVID vaccine maker Clover Biopharma set for HKEX debut
Nikkei Asia - 04 Nov 2021
Chinese COVID vaccine maker Clover Biopharma set for HKEX debut ...
Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial ...
PR Newswire - 22 Sep 2021
Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial ... ...
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile ...
ScienceDirect.com - 07 Dec 2023
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile ... ...
Bill Gates-backed Clover raises $240M in IPO with Delta-tested COVID vaccine
Fortune - 05 Nov 2021
Bill Gates-backed Clover raises $240M in IPO with Delta-tested COVID vaccine ...
Philippines troops and ministers get COVID-19 vaccine before approval
The Japan Times - 28 Dec 2020
Philippines troops and ministers get COVID-19 vaccine before approval ...
Clover Biopharma launches COVID-19 booster vaccine in China
BSA bureau - 16 Feb 2023
Clover Biopharma launches COVID-19 booster vaccine in China ...
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern | npj Vaccines
Nature.com - 12 Nov 2022
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern | npj Vaccines ...
Clover collaborates with Kyuan Trade to launch AdimFlu-S (QIS) in China
Pharmaceutical Technology - 25 May 2023
Clover collaborates with Kyuan Trade to launch AdimFlu-S (QIS) in China ...
Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing
PR Newswire - 22 Feb 2021
Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing ...
Clover Biopharmaceuticals begins Covid-19 vaccine booster trial
Pharmaceutical Technology - 26 Nov 2021
Clover Biopharmaceuticals begins Covid-19 vaccine booster trial ...
Clover to use GSK's adjuvant system for Covid-19 vaccine candidate
Pharmaceutical Technology - 25 Feb 2020
Clover to use GSK's adjuvant system for Covid-19 vaccine candidate ...